About RR Pharmaceuticals
RR Pharmaceuticals is a company based in Delhi (India) founded in 2012. It operates as a B2B. RR Pharmaceuticals offers products and services including Azacitidine for Injection, Ritonavir Tablets, Docetaxel Injection, Lopinavir and Ritonavir Tablets, and Capecitabine Tablets. RR Pharmaceuticals operates in a competitive market with competitors including AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.
- Headquarter Delhi, India
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Rr Pharmaceuticals Private Limited
- Date of Incorporation 01 Aug, 2012
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$1.82 M (USD)59.33as on Mar 31, 2023
-
Net Profit
$11.38 K (USD)8.14as on Mar 31, 2023
-
EBITDA
$46.35 K (USD)-34.18as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RR Pharmaceuticals
RR Pharmaceuticals offers a comprehensive portfolio of products and services, including Azacitidine for Injection, Ritonavir Tablets, Docetaxel Injection, Lopinavir and Ritonavir Tablets, and Capecitabine Tablets.
Injection used for treating myelodysplastic syndrome and leukemia.
Antiviral tablet for managing HIV infections effectively.
Chemotherapy injection for breast and prostate cancer treatment.
Combined tablet for HIV therapy and viral load reduction.
Oral medication for metastatic breast and colorectal cancers.
Capsule to suppress HIV replication in infected patients.
Tablet for treating chronic myeloid leukemia and tumors.
Injection therapy for lung cancer and mesothelioma cases.
Funding Insights of RR Pharmaceuticals
Detailed funding history for RR Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RR Pharmaceuticals
Investment portfolio details for RR Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RR Pharmaceuticals
Detailed financials for RR Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rr Pharmaceuticals Comparisons
Peer comparison for RR Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RR Pharmaceuticals
RR Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| Locked | Locked | Locked |
India's leading healthcare products distribution platform
|
|
| Locked | Locked | Locked |
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed.
|
|
| Locked | Locked | Locked |
Provider of medical equipment, devices, and drugs distribution services
|
|
| Locked | Locked | Locked |
Serves as a distributor of a wide range of pharmaceutical drugs.
|
|
| Locked | Locked | Locked |
Distributor of pharmaceutical raw materials
|
Detailed competitors of RR Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rr Pharmaceuticals
Complete news archive for RR Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RR Pharmaceuticals
RR Pharmaceuticals was founded in 2012.
RR Pharmaceuticals is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Annual revenue of RR Pharmaceuticals is $1.82M as on Mar 31, 2023.
RR Pharmaceuticals specializes in distributing pharmaceutical products, including oncology injectables and solid orals, as well as ARV medications. With over 35 years of experience, they offer customized logistics solutions, warehousing, and transportation services to businesses worldwide. Based in New Delhi, India, they ensure efficient delivery and real-time tracking, serving clients from startups to large corporations with a focus on quality and reliability.
RR Pharmaceuticals's top competitors include Entero Healthcare, AmerisourceBergen and Keimed.
RR Pharmaceuticals offers Azacitidine for Injection, Ritonavir Tablets, Docetaxel Injection, Lopinavir and Ritonavir Tablets, and 4 more products and services.